| « Previous month | Next month » |
30-Sep-2008 - DSM has invested in The Compliers Group (TCG), a company developing pharmaceutical packaging containing microchips to monitor a patient's compliance.
30-Sep-2008 - Syrris has become the primary marketer for Prosonix’s new SonoLab laboratory scale sonocrystallisation and sonoprocessing equipment.
30-Sep-2008 - in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from Premier Pneumatics, GE Healthcare and WaterSep.
29-Sep-2008 - Ahura Scientific has launched an updated version of its TruScan handheld instrument, which allows for raw materials to be quickly verified.
29-Sep-2008 - Ranbaxy’s antiretrovirals zidovudine, lamivudine, and nevirapine have been removed from PEPFAR’s list of approved products until ongoing GMP problems at two of the firm’s Indian manufacturing plants are resolved. ...
29-Sep-2008 - Sagent Pharmaceuticals has acquired the rights to a patented, multi-chamber, sequential dose syringe from Infusive Technologies.
28-Sep-2008 - BioTrove has launched a series of assay panels that enable researchers to skip the laborious initial steps of gene selection and assay optimisation and start studying disease pathways straightaway.
26-Sep-2008 - TTP LabTech has transformed its ‘mosquito’ nanolitre liquid handler into a highly flexible system for preparing microplates for high throughput (HT) screening applications.
25-Sep-2008 - Chinese packaging specialist Dragon International is seeking SFDA marketing approval for a new composite film product for the suppository drug market.
25-Sep-2008 - Teva and Kowa have set their sights on Japan’s $4.6bn (€3.1bn) generics market with their development and manufacturing joint venture Teva-Kowa Pharma.
25-Sep-2008 - Alpharma has licensed an investigational transdermal bupivacaine patch from Durect for an initial $20m, with further payments based on reaching developmental milestones.
24-Sep-2008 - in-PharmaTechnologist.com’s periodic round-up of developments in the pharmaceutical manufacturing space includes news on MannKind, Nycomed, ABS and Tris.
24-Sep-2008 - Prosonix, a specialist developer of ultrasonic industrial processing solutions, says that global drug giant Pfizer is to begin using its Prosonitron reactor and sonocrystallisation technology at its manufacturing facility in...
24-Sep-2008 - A domino effect appears to have been started by the FDA blocking Ranbaxy imports, with other regulatory bodies paying close attention to the generics giant.
24-Sep-2008 - The production of pharmaceutical products in plant cells has been given a boost, after the European Union ploughed $8.8m into a research programme.
23-Sep-2008 - Sanofi-Aventis’ €1.8bn ($2.6bn) offer for Czech generics firm Zentiva has been unanimously accepted by the latter firm’s board after four months of wrangling that has seen the bid increase by...
23-Sep-2008 - The WHO has issued Sandoz with a Notice of Concern (NoC) after an inspection of the firm’s Kempton Park facility in South Africa identified 41 deviations from GMP standards. ...
23-Sep-2008 - The US Food and Drug Administration (FDA) has issued draft guidance for the use of genetically engineered (GE) animals to produce drugs.
23-Sep-2008 - in-PharmaTechnologist.com presents its latest round-up of personnel changes in the pharmaceutical sector.
22-Sep-2008 - Dutch chemicals giant DSM and France’s LibraGen are targeting the chemical and pharmaceutical industries with their new chiral amine production accord, which aims to develop a range of new catalytic...
22-Sep-2008 - EnWave says that its freezeREV dehydration technology can reduce the moisture content of single vial vaccines to between 3 and 3.5 per cent, bettering the mark achieved by its bioREV...
22-Sep-2008 - Germany-based Diapharm has launched a service allowing pharmaceutical manufacturers to perform joint third-party audits of active pharmaceutical ingredients (APIs).
22-Sep-2008 - Massachusetts needs to do more to produce workers for its life sciences industry if it is to avoid a skills shortage in years to come, according to research.
22-Sep-2008 - UK-based Reaxa and Switzerland’s RohnerChem have teamed up to develop the former’s EnCat catalyst technology for industrial applications in the API and drug manufacturing sector.
19-Sep-2008 - Despite the credit crunch, Invitrogen’s acquisition of ABI (Applied Biosystems) is expected to be complete by early November and details of how the merged entity will be structured have just...
19-Sep-2008 - UK-based deltaDOT has launched a new assay that dramatically reduces the time needed to quantify the number of baculovirus expression vectors present in a sample.
19-Sep-2008 - European researchers have devised a method of purifying parasites that will enable scientists to gain deeper insights into the biology of the organisms responsible for millions of infections every year....
18-Sep-2008 - CMO NextPharma has signed a deal to make Aseptic Technologies “revolutionary” ‘closed-vial’ filling system available as part of its offering to clients.
18-Sep-2008 - Oral dose filling specialist Capsugel hopes that its new Xcelohood containment system will improve industrial weighing operations during the preparation of high-potency drugs.
18-Sep-2008 - DSM Biomedical and Caliber Therapeutics aim to expand their presence in the balloon catheter market with a project to develop new drug delivery devices for vascular diseases, including atherosclerosis.
18-Sep-2008 - IPEC China must become a “harmonisation bridge between China and other countries,” according to Colorcon’s Nevin Cheng who was recently elected chairman of the new organisation.
18-Sep-2008 - BioGeneriX and Novo Nordisk have signed deals to acquire most of Neose Technologies’ intellectual property for a combined total of $43m.
17-Sep-2008 - The FDA has issued generics giant Ranbaxy Laboratories with two warning letters, detailing “extensive deviations from US cGMP requirements” at the firm’s manufacturing plants in Dewas and Paonta Sahib, India. ...
17-Sep-2008 - MannKind’s inhaled insulin treatment, Technosphere, has met its study goal in the first of three Phase III trials, leading to Pfizer transferring its remaining Exubera patients to the treatment.
17-Sep-2008 - Formatech hopes its new formulation method, which solubilises compounds in micelles consisting of fatty acids or alcohols, will improve both the safety and bioavailability of pharmaceutical products.
17-Sep-2008 - A surge in research into novel drug delivery systems will occur as companies seek to differentiate their products in response to pressure from biosimilars, according to a publication from Frost...
16-Sep-2008 - in-PharmaTechnologist.com's latest round-up of developments in pharmaceutical manufacturing features news of the world’s “biggest pharmaceutical allergen production unit”, Lentigen’s relocation and a cytotoxic robot.
16-Sep-2008 - Millipore is planning on closing four facilities, generating annual savings of up to $15m, as it attempts to cut costs by streamlining its operations.
16-Sep-2008 - The US Food and Drug Administration (FDA) has granted fast track designation to Neurotech’s treatment for two ocular diseases.
16-Sep-2008 - Artelis president Jose Castilo believes that the record MAb yield from CHO cells grown in its iCELLis bioreactor shows the platform could shift the paradigm for the "production of recombinant...
15-Sep-2008 - APP Pharmaceuticals has bought additional facilities at a site in Grand Island, New York seizing the opportunity created by Astellas Manufacturing’s decision to shift production of its dermatitis drug Protopic...
15-Sep-2008 - US drug delivery specialist MonoSol Rx says it has received USPTO patent rights to processes used in the manufacture of PharmFilm, its proprietary thin film drug delivery technology.
15-Sep-2008 - Australian proteomics fluorescence expert Fluorotechnics has agreed to buy The Gel Company as part of its strategy to cement itself as a world leader in protein electrophoresis.
15-Sep-2008 - Speculation is rife that Australia’s Amcor is one of several companies to have tabled bids for Rio Tinto’s $4.4bn (€3.1bn) Alcan Packaging division that serves the pharmaceutical, food and tobacco...
15-Sep-2008 - Agilent and Millipore have formed a collaboration to develop fully validated chromatin immunoprecipitation (ChIP) microarray kits that will improve productivity and streamline epigenetic analysis.
15-Sep-2008 - Revised good manufacturing practice (GMP) requirements for the production of radiopharmaceuticals have been published by the European Commission (EC).
15-Sep-2008 - A nanoparticle capable of carrying a soluble and insoluble drug has been created for the delivery of combination therapies, according to research published in Nature.
11-Sep-2008 - Companies have failed to provide the information needed under the USP’s new chapter regarding residual solvents, causing them to incorrectly file ANDAs, according to the Office of Generic Drugs (OGD)....
11-Sep-2008 - As the December 31 deadline for the removal of CFC albuterol inhalers in the US approaches, a new report by Kalorama Information forecasts big changes in the global $36bn (€26bn)...
11-Sep-2008 - CSL Biotherapies, part of Australia’s CSL group, has begun shipping the first of six million doses of its thimerosal-free vaccine Afluria to the US CDC ahead of this year’s flu...
11-Sep-2008 - GlaxoSmithKline’s head of North American operations, Chris Viehbacher, is to takeover as chief operating officer (CEO) at Sanofi-Aventis after he missed out on the top spot at GSK last year....
10-Sep-2008 - Sandoz Canada, a unit of Novartis’ generics arm, has opened a second manufacturing plant at its site in Boucherville, Quebec, boosting local production capacity 66 per cent.
10-Sep-2008 - Haupt Pharma has completed its merger with fellow German companies Amareg and Wülfing Pharma to create a major new force in the European contract development and manufacturing sector, with around...
10-Sep-2008 - The FDA has granted sNDA approval for Akorn’s IC-Green injection dye, which is the first lyophilised product manufacturered at the firm’s Decatur facility to gain such status. ...
10-Sep-2008 - in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from Genevac, Lock and AdvantaPure.
10-Sep-2008 - Gene therapy could be advanced by a worm more commonly associated with causing a deadly parasitic disease, according to researchers presenting at the British Pharmaceutical Conference (BPC).
09-Sep-2008 - Indian pharmaceutical firm Alembic is seeking to expand its presence in the lucrative US and European drug markets through an expanded partnering programme.
09-Sep-2008 - The US Food and Drug Administration (FDA) has published its latest amendments to current good manufacturing practice (cGMP) regulations.
09-Sep-2008 - Abraxis has licensed rights to use ProMetic’s protein technology in the development of four new biopharmaceuticals that it hopes will generate around $600m (€422.5m) in US sales.
09-Sep-2008 - A list of drugs currently being evaluated for potential safety issues by the US Food and Drug Administration (FDA) has been posted on its website.
08-Sep-2008 - in-PharmaTechnologist.com presents its latest round-up of personnel changes in the pharmaceutical sector.
08-Sep-2008 - US fine and industrial chemicals specialist Aceto says that its expansion on the global stage, particularly in Europe and Asia, is starting to pay financial dividends.
08-Sep-2008 - Despite a decade-long build up, drugmakers are yet to wake up to the “no data, no market” mantra of the EC’s REACH legislation, according to SAFC’s marketing director Amanda Halford. ...
08-Sep-2008 - US scientists have discovered a new threat to the US honeybee population using technology developed for detecting viruses on the battlefield.
08-Sep-2008 - UK researchers have developed two synthetic molecules that coax stem cells to differentiate into either neurons or epithelial cells for use in drug discovery applications.
08-Sep-2008 - Tocris Bioscience has launched a new search facility that enables researchers to search for chemicals by the biological targets they work on, rather than the chemical name itself.
04-Sep-2008 - Growth in licensing deals between large drugmakers companies and their smaller, research-based counterparts continued apace in 2007, but the average total value of each deal has started to fall.
04-Sep-2008 - Drug delivery specialist BioAlliance Pharma says that its decision to focus on the oncology and infectious disease markets helped it reduce its half-year 2008 losses.
04-Sep-2008 - US fine chemical company Sigma-Aldrich said this morning that subsidiary SAFC Pharma has kicked off a $30m expansion plan for its active high-potency pharmaceutical ingredient (API) manufacturing facility in Madison,...
03-Sep-2008 - Canada’s Bioxel Pharma believes that the six new generic docetaxel supply deals it has signed, represents a real leap forward in its business plan
03-Sep-2008 - in-PharmaTechnologist.com's periodic round-up of developments and deals in the pharmaceutical manufacturing space, includes news on 3M and Ligacon, Dishman, Stiefel and Barrier and Forbes.
03-Sep-2008 - UK and Swedish researchers have developed a system that eliminates the need for antibiotics and resistance genes in the engineering of biopharmaceutical products, making the process both safer and less...
02-Sep-2008 - UK-based polymer technology specialist Chromatide and Akzo Nobel's Separation Products (SP) unit are teaming to develop a HPLC media for purification applications in the drug manufacturing industry.
02-Sep-2008 - bioMerieux hopes that its new specially-packaged growth media products will help it “clean up” in the pharmaceutical industry’s lucrative sterility testing market
02-Sep-2008 - Japan’s Shionogi is paying $1.4bn (€959m) for US drugmaker Sciele Pharma as part of a plan to strengthen its sales position in the country’s $286bn a year drug market. ...
01-Sep-2008 - Contract services firm Marksans Pharmaceutical says that the RPS 1bn (€15.4m) acquisition of UK generics group Relonchem will expand its distribution network and build its presence in the European market....
01-Sep-2008 - UCB is moving forward with efforts to focus on CNS disorders and immunology and plans to cut around 2,000 jobs as part of its SHAPE restructuring program.
| « Previous month | Next month » |